Toronto Star: Former Canopy CEO and co-founder envisions big opportunity in psychedelics

By Armina Ligaya Toronto Start, Sep 17,2019

He sees the opportunity for psychedelics as medicine as similar to the outlook for medicinal cannabis years ago, where regulations were starting to ease in some jurisdictions, opening the door for research.

“There’s probably untapped value, which will only go to the people who are at the beginning and bold,” he said in an interview.